Uric acid-related nephrolithiasis (Q41362039)

29 September 2017

1 reference

title

Uric acid-related nephrolithiasis (English)

1 reference

29 September 2017

Low RK

1

1 reference

PubMed ID

9048857

29 September 2017

Stoller ML

series ordinal

2

1 reference

29 September 2017

1 February 1997

1 reference

Urologic Clinics of North America

29 September 2017

1 reference

29 September 2017

24

1 reference

29 September 2017

1

1 reference

29 September 2017

135-148

1 reference

Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol

29 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

RENAL AMMONIUM EXCRETION AND URINARY PH IN IDIOPATHIC URIC ACID LITHIASIS

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Gout with purine overproduction due to increased phosphoribosylpyrophosphate synthetase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Chemolysis of residual stone fragments after extensive surgery for staghorn calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Ammonia, urea and uric acid content of toenails in renal insufficiency and gout

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Hyperuricosuric calcium oxalate nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Renal-stone dissolution via percutaneous nephrostomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

1 reference

7 January 2021

Adenine phosphoribosyltransferase deficiency: its inheritance and occurrence in a female with gout and renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Randomized trial of allopurinol in the prevention of calcium oxalate calculi.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

The Alternating Use of an Alkalizing Salt and Acetazolamide in the Management of Cystine and Uric Acid Stones

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Urolithiasis as a complication of chronic diarrheal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Uric acid nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

URINARY AMMONIUM EXCRETION IN PRIMARY GOUT

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Epidemiology of gout and hyperuricemia. A long-term population study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

The metabolism defect responsible for uric acid stone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Dissolution of Uric Acid Calculi with Systemic Alkalization

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

2,8-Dihydroxyadenine urolithiasis: report of a case in a woman in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

UROLITHIASIS AS A COMPLICATION OF THE SURGICAL TREATMENT OF ULCERATIVE COLITIS.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Clinical and laboratory studies of 207 consecutive patients in a kidney-stone clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

THE DISTRIBUTION OF SERUM URIC ACID VALUES IN A POPULATION UNSELECTED AS TO GOUT OR HYPERURICEMIA: TECUMSEH, MICHIGAN 1959-1960

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Effect of oestrogen therapy on plasma and urinary levels of uric acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Successful management of uric acid nephrolithiasis with potassium citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Prophylaxis of Uric Acid Stones With Alternate Day Doses of Alkaline Potassium Salts

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

1 reference

7 January 2021

Experimental observations on dissolution of uric acid calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Assessment of the pathogenetic role of physical exercise in renal stone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Uric acid production in gout

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Management of Asymptomatic Hyperuricemia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Gout and stones or stones and gout?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Effect of orange juice consumption on urinary stone risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Severe allopurinol hypersensitivity. Association with thiazides and prior renal compromise

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Uric acid nephrolithiasis in gout. Predisposing factors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

Natural urinary macromolecular inhibitors: attenuation of inhibitory activity by urate salts

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970359-1

7 January 2021

10.1016/S0094-0143(05)70359-1

Identifiers

DOI

1 reference

29 September 2017

1 reference

PubMed ID

9048857